Human β-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells

Infection and Immunity

Volumn 73, Issue 8, 2005, Pages 4505-4511

  Rivas Santiago, Bruno ^a,b   Schwander, Stephan K ^c   Sarabia, Carmen ^b   Diamond, Gill ^d   Klein Patel, Marcia E ^d   Hernandez Pando, Rogelio ^e   Ellner, Jerrold J ^c   Sada, Eduardo ^b  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^e INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; LIPOARABINOMANNAN; MESSENGER RNA;

ARTICLE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; ELECTRON MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBERCULOSIS;

BETA-DEFENSINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, IMMUNOELECTRON; MYCOBACTERIUM TUBERCULOSIS; PULMONARY ALVEOLI; RESPIRATORY MUCOSA; TUBERCULOSIS, PULMONARY;

EID: 23344443341     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.8.4505-4511.2005     Document Type: Article

References (47)

1. Ashitani, J., H. Mukae, T. Hiratsuka, M. Nakazato, K. Kumamoto, and S. Matsukura 2001. Plasma and BAL fluid concentrations of antimicrobial peptides in patients with Mycobacterium avium-intracellulare infection. Chest 119:1131-1137.
2. Bals, R., X. Wang, Wu, Z., T. Freeman, V. Banfa, M. Zasloff, and J. Wilson 1998. HBD-2 is a salt sensitivity peptide antibiotic expressed in human lung. Clin. Investig. 102:874-880.
3. Bals, R. 2000. Epithelial peptides in host defense against infection. Respir. Res. 1:141-150.
4. Bermudez, L. E., and J. Goodman. 1996. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun. 64:1400-1406.
5. Birchler, T., R. Seibl, K. Buchner, S. Loeliger, R. Seger, J. P. Hossle, A. Aguzzi, and R. P. Lauener 2001. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur. J. Immunol. 31:3131-3137.
6. Chatterjee, D., S. W. Hunter, M. McNeil, I. Jardine, and P. J. Brennan 1992. Structure and function of mycobacterial glycolipids and glycopeptidolipids. Acta Leprol. 7(Suppl. 1):81-84.
7. Cooper, A. M., J. E Callahan,. M. Keen, J. T. Belisle, and I. M. Orme 1997. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tuber. Lung Dis. 78:67-73.
8. + T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J. Immunol. 9:4689-4699.
9. Diamond, G,. M. Zasloff, H. Eck, M. Brasseur, W. L. Maloy, and C. L. Bevins 1991. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc. Natl. Acad. Sci. USA 88:3952-3956.
10. Duits, L., M. Rademaker, and B. Ravensbergen 2001. Inhibition of HBD-3 but not HBD-1 and HBD-2, mRNA expression by corticosteroids. Biochem. Biophys. Res. 280:522-525.
11. Duits, L., B. Ravensbergen, M. Rademaker, P. Hiemstra, and P. Nibbering 2002. Expression of β-defensin 1 and 2 mRNA by human monocytes, macrophages and dendric cells. Immunology 106:517-525.
12. Durr, M., and A. Peschel 2002. Chemokine meet defensin: the emerging concepts of chemoattractants and antimicrobial peptides in host defense. Infect. Immun. 70:6515-6518.
13. Dye, C., S. Scheele, V. Dolin, T. Pathania, and M. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. W.H.O. global surveillance and monitoring project. JAMA 282:677-686.
14. Ellner, J., C. Hirsch, and C. Whalen 2000. Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin. Infect. Dis. 30(Suppl. 3):S279-S282.
15. Reference deleted.
16. Fang, X. M., Q. Shu, Q. X. Chen, M. Book, H. G. Sahl, A. Hoeft, and F. Stuber 2003. Differential expression of alpha- and beta-defensins in human peripheral blood. Eur. J. Clin. Investig. 1:82-87.
17. Garcia, J. R., A. Krause, S. Schulz, F. J. Rodriguez-Jimenez, E. Kluver, K. Adermann, U. Forssmann, A. Frimpong-Boateng, R. Bals, and W. G. Forssmann 2001. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 10:1819-1821.
18. Gilleron, M,. L. Bala, T. Brando, A. Vercellone, and G. Puzo 2000. Mycobacterium tuberculosis H37Rv parietal and cellular lipoarabinomannans. Characterization of the acyl- and glyco-forms. Biol. Chem. 1:677-684.
19. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Kari, and M. Zassloff 1997. Human β-defensin-1 is a salt-sensitive antibiotic in the lung that is inactivated in cystic fibrosis. Cell 88:553-560.
20. Harder, J., U. Meyer-Hoffert, and L. M. Teran 2000. Mucoid Pseudomonas aeruginosa, TNFα and IL1β, but not IL-6 induce HBD-2 in respiratory epithelia. Am. J. Respir. Cell Mol. Biol. 26:714-721.
21. Harder, J., J. Bartels, and E. Christophers 2001. Isolation and characterization of human beta defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707-5713.
22. Hernandez-Pando, R., D. Aguilar, M. L. Hernandez, H. Orozco, and G. Rook 2004. Pulmonary tuberculosis in BALB/c mice with non-functional IL-4 genes: changes in the inflammatory effects of TNF-alpha and in the regulation of fibrosis. Eur. J. Immunol. 1:174-183.
23. Hernandez-Pando, R., M. Jeyanathan, G. Mengistu, D. Aguilar, H. Orozco, M. Harboe, G. A. Rook, and G. Bjune 2000. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 356:2133-2138.
24. Hiratsuka, T., M. Nakazato, Y. Date, J. Ashitani, T. Minematsu, N. Chino, and S. Matsukara 1998. Identification of β-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem. Biophys. Res. Commun. 249:943-947.
25. Hoover, D. M., K. K. Rajashankar, R. Blumenthal, A. Puri, J. J. Oppenheim, O. Chertov, and J. Lubkowski 2000. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 42:32911-32918.
26. Kaiser, V., and G. Diamond 2000. Expression of mammalian defensin genes. J. Leukoc. Biol. 68:779-784.
27. Kao, C. Y., Y. Chen, Y. H. Zhao, and R. Wu. 2003. ORFeome-based search of airway epithelial cell-specific novel human [beta]-defensin genes. Am. J. Respir. Cell Mol. Biol. 29:71-80.
28. Kisich, K., L. Heifets, M. Higgins, and G. Diamond 2001. Antimycobacterial agent based on mRNA encoding human β-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis. Infect. Immun. 69:2692-2699.
29. Lehrer, R., A. Lichtenstein, and T. Ganz 1993. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11:105-128.
30. Lin, Y., M. Zhang, and P. F. Barnes 1998. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect. Immun. 66:1121-1126.
31. Linzmeier, R., Ho, and C. H., T. Ganz 1999. A 450-kb contig of defensin genes on human chromosome 8p23. Gene 233:205-211.
32. Madan, T., S. Saxena, K. J. Murthy, K. Muralidhar, and P. U. Sarma. 2002. Association of polymorphisms in the collagen region of human SP-A1 and SP-A2 genes with pulmonary tuberculosis in Indian population. Clin. Chem. Lab. Med. 10:1002-1008.
33. North, R. J., R. Lacourse, and L. Ryan 1999. Vaccinated mice remain more susceptible to Mycobacterium tuberculosis infection initiated via the respiratory route than via the intravenous route. Infect Immun. 67:2010-2012.
34. Rodriguez-Jimenez, F. J., A. Krause, S. Schulz, W. G. Forssmann, J. R. Conejo-Garcia, R. Schreeb, and D. Motzkus. 2003. Distribution of new human beta-defensin genes clustered on chromosome 20 in functionally different segments of epididymis. Genomics 81:175-183.
35. Schlesinger, L. S., S. R Hull, and T. M. Kaufman. 1994. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J. Immunol. 152:4070-4079.
36. Schutte, B. C., J. P. Mitros, J. A. Bartlett, J. D. Walters, H. P. Jia, M. J. Welsh, T. L. Casavant, and P. B. McCray, Jr. 2002. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc. Natl. Acad. Sci. USA 99:2129-2133.
37. Schwander, S. K., M. Torres, E. Sada, C. Carranza, E. Ramos, M. Tary-Lehmann, R. S. Wallis, J. Sierra, and E. A. Rich 1998. Enhanced responses to Mycobacterium tuberculosis antigens by alveolar lymphocytes during active pulmonary tuberculosis. J. Infect. Dis. 178:1434-1445.
38. Schwander, S. K., M. Torres, C. C. Carranza, D. Escobedo, M. Tary-Lehmann, P. Anderson, Z. Toossi, J. J. Ellner, E. A. Rich, and E. Sada. 2000. Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J. Immunol. 165:1479-1485.
39. Singh, P., H. Jia, K. Wiles, J. Hesselberth, L. Liu, B. Conway, E. Greenberg, E. Valore, M. Welsh, T. Ganz, B. Tack, and P. J. McCray 1998. Production of β-defensin by human airway epithelia. Proc. Natl. Sci. USA 95:14961-14966.
40. Smith, J., S. Travis, E. Greenberg, and M. Welsh 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 2:229-236.
41. 40a. Stolzenberg, E. D., G. M. Anderson, M. R. Ackermann, R. H. Whitlock, and M. Zasloff. 1997. Epithelial antibiotic induced in states of disease. Proc. Natl. Acad. Sci. USA 94:8686-8690.
42. Tapping, R. I., and P. S. Tobias 2003. Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. J. Endotoxin Res. 4:264-268.
43. Tsutsumi-Ishii, Y., and I. Nagaoka. 2003. Modulation of human β-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J. Immunol. 170:4226-4236.
44. van Crevel, R., T. Ottenhof, and J. van der Meer 2003. Innate immunity to Mycobacterium tuberculosis. Adv. Exp. Med. Biol. 531:294-309.
45. van Rie, A., R. Warren, M. Richardson, T. C. Victor, R. P. Gie, A. Enarson, N. Beyers, and P. D. van Heiden 1999. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med. 341:1174-1179.
46. World Health Organization. 2004. Global tuberculosis control: surveillance, planning, financing. W.H.O. report 18-38. World Health Organization, Geneva Switzerland.
47. Yang, D., O. Chertov, S. N. Bykovskaia, Q. Chen, M. J. Buffo, J. Shogan, M. Anderson, J. M. Schroder, J. M. Wang, O. M. Howard, and J. J. Oppenheim 1999. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-528.